UterineKind
UterineKind is a Boston-based digital health company offering a free symptom-tracking app and a paid 100-day care navigation program led by Board Certified Patient Advocates, serving women whose chronic gynecologic conditions have been dismissed or underdiagnosed.
- Company typePrivate
- Founded2022
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What UterineKind does
UterineKind is a Boston-based, privately held digital health company founded in January 2022 by Carol Johnson after pivoting from her prior creative agency (Advocats Agency). The company targets individuals — primarily women and adolescent girls — whose symptoms of chronic gynecologic conditions (endometriosis, fibroids, PCOS, PMDD, adenomyosis, AUB, chronic pelvic pain, pelvic inflammatory disease, uterine prolapse) are dismissed or underdiagnosed by traditional healthcare providers. The stated goal is to compress a diagnostic timeline that typically runs years into a 100-day engagement window.
The company's product surface is built on a proprietary mobile and Progressive Web Application offering structured daily symptom tracking across six categories (Pain, Mental Health, Body, Sleep, Energy, Bleeding) with four severity levels and detailed sub-symptoms, an automated physician-ready symptom summary report generator, a private health diary, and an in-app educational content library. The app is paired with a paid 100-day care navigation program staffed by Board Certified Patient Advocates (BCPAs), which provides education, physician referrals to vetted specialists, weekly check-ins, unlimited chat, and HIPAA-compliant communications. The platform is HIPAA-, GDPR-, and CCPA-compliant, uses Stripe for payments, and is distributed via the Apple App Store and a web app. Adjacent offerings include the Hello Uterus podcast (an educational sub-brand) and a donation-funded menstrual health education program (10% of all revenue is allocated to female/reproductive health research).
The business model is freemium: the app is free with no paywalls or advertising and serves as the top-of-funnel acquisition channel, while the BCPA care program is the sole monetized product and is sold direct-to-consumer via the company website on a multi-year subscription structure (HSA/FSA eligible). UterineKind is bootstrapped and founder-owned with no disclosed venture funding, operates with a team of 1–10, and is supported by formal partnerships with the Lujan Laboratory at Cornell, the Metz-Gregersen Laboratory at the Feinstein Institutes for Medical Research, and senior medical advisors from Keck School of Medicine USC, Massachusetts General Hospital, and the University of Maryland School of Medicine.
UterineKind firmographics
Firmographics- Name
- UterineKind
- Legal name
- UterineKind, Inc.
- Website
- https://uterinekind.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- UterineKind is a Boston-based digital health company offering a free symptom-tracking app and a paid 100-day care navigation program led by Board Certified Patient Advocates, serving women whose chronic gynecologic conditions have been dismissed or underdiagnosed.
- Ownership category
- akta.pro rank
UterineKind industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Family Planning Centers (621410)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)
- akta.pro secondary industry
- Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)
Keywords
Where UterineKind is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
UterineKind business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Care Navigation Program Subscription: The 100-day Board Certified Patient Advocate (BCPA) care navigation program is the primary paid product. Includes BCPA consultations, care coordination, physician vetting and referral services, and 1-year app access. Program is HSA/FSA eligible for reimbursement.
- Mobile Application (Free): Core mobile application is provided free of charge with no paywalls or advertisements. Serves as the primary acquisition and engagement channel for the paid care program.
- Diagnostic Services Coordination: BCPAs assist in identifying cost-effective diagnostic services (labs, imaging), negotiating cash-pay rates, and maximizing insurance coverage, though diagnostic tests themselves are not included in the program fee
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free Mobile App |
| Subscription | Multi-year contract | 100-Day BCPA Care Navigation Program |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
UterineKind product offering
Product offeringCore offering
UterineKind is a direct-to-consumer women's health platform that combines a free mobile and Progressive Web App for daily symptom tracking with a paid 100-day Board Certified Patient Advocate (BCPA) care navigation subscription. The platform helps women with chronic gynecologic conditions document symptoms, generate structured reports for clinical visits, and receive personalized advocacy and care coordination from credentialed patient advocates.
Product overview
UterineKind offers a two-product platform: the UterineKind App (a free symptom-tracking and educational mobile/PWA tool) and the UterineKind Care Program (a paid 100-day advocate-led care navigation service). These products work together — the app provides ongoing symptom monitoring and education while the Care Program offers intensive BCPA support, physician referrals, and structured guidance over 100 days. The company also produces the Hello Uterus Podcast as an educational resource and operates a donation program for menstrual health education.
Differentiator
Problem solved
Functional benefit
Brands
- Hello Uterus Podcast: A podcast featuring episodes discussing reproductive health topics, featuring interviews with physicians, researchers, and patients on conditions like endometriosis, fibroids, PCOS, and reproductive justice.
Products and services
- UterineKind Symptom Tracking App
- UterineKind BCPA Care Navigation Program
Companies that use UterineKind
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
UterineKind technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
UterineKind partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- Lujan Laboratory at Cornell UniversitycoreUterineKind Partner Lab investigating the link between nutrition, metabolism and reproductive physiology in females, with particular expertise in Polycystic Ovarian Syndrome (PCOS). Marla Lujan, Ph.D. serves as Principal Investigator and Associate Professor of Human Nutrition. The partnership supports research funding and scientific collaboration.
- Metz-Gregersen Laboratory at Feinstein Institutes for Medical ResearchcoreUterineKind Partner Lab conducting the ROSE Study (Research Outsmarts Endometriosis). Led by Christine Metz, Ph.D. and Peter Gregersen, MD. The partnership funds endometriosis research and supports the scientific community working on this condition.
- Keck Medicine of USCsupportingDr. Evelyn Nicole Mitchell serves as Senior Medical Advisor, holding positions as Clinical Assistant Professor of Obstetrics and Gynecology and Director of Diversity, Equity, and Inclusion of Obstetrics and Gynecology at Keck School of Medicine, USC.
- Massachusetts General HospitalsupportingDr. John Petrozza serves as Senior Medical Advisor. He is a Reproductive Endocrinologist and Reproductive Surgeon, Chief of Division of Reproductive Medicine and IVF, and Director of Massachusetts General Fertility Center, and Co-Director of the MGH Integrated Fibroid Program.
- University of Maryland School of MedicinesupportingDr. Irina Burd serves as Medical Content Reviewer. She is Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Maryland, Baltimore.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
UterineKind competitors and assessment
Company assessmentBroad incumbents
- Kindbody: Kindbody is a fertility and reproductive health company with clinics and virtual care spanning fertility, gynecology, and wellness. Relevant given UterineKind's reproductive endocrinology medical advisory and addressable audience of women with fertility-impacting conditions.
- Tia: Tia operates a women's health platform combining virtual and in-person care with a focus on whole-person gynecology, mental health, and primary care. Comparable to UterineKind in addressing dismissed women's health symptoms, but with brick-and-mortar clinics and broader scope.
- Maven Clinic: Maven is a large virtual-care platform for women's and family health with employer and payer contracts. It is a broader incumbent offering care navigation and specialist access across fertility, maternity, and gynecology, directly comparable to UterineKind's BCPA-led care navigation model.
- Hims & Hers (Hers): Hers is a scaled direct-to-consumer women's telehealth and wellness brand. It competes for the same consumer acquisition channels and overlapping use cases (contraception, PCOS, hormonal health), making it a broad incumbent peer for UterineKind's D2C model.
Direct peers
- Clue: Clue is a leading period and cycle tracking app with evidence-based content and a subscription tier. It competes head-to-head with the UterineKind app for symptom-tracking share, especially among users seeking physician-shareable data.
- Wisp: Wisp provides direct-to-consumer telehealth for women's reproductive health, including UTI, STI, and contraception care. Comparable to UterineKind in D2C women's telehealth and addressing symptoms that are commonly dismissed or undertreated.
- Flo Health: Flo is the largest period and symptom tracking app globally, with a freemium model and premium AI insights. It directly overlaps with UterineKind's free symptom-tracking mobile app and competes for the same audience of women tracking reproductive health symptoms.
- Twentyeight Health: Twentyeight Health is a telehealth platform delivering women's reproductive and sexual health care, including contraception, with a strong focus on underserved populations. Comparable to UterineKind in providing accessible women's telehealth plus care navigation.
Emerging players
- Mahmee: Mahmee is a maternal and infant health platform offering care navigation and in-person support for pregnancies and postpartum. It overlaps with UterineKind's care navigation model and audience of women with chronic gynecologic conditions that often intersect with maternal health.
- Elektra Health: Elektra Health is a women's health platform focused on menopause care navigation with clinician and community support. It is an emerging peer with a similar care-navigation-plus-education model, though focused on a different life stage than UterineKind.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
UterineKind social profiles
Digital presenceUterineKind compliance and trust
Trust signalCompliance3 records
UterineKind financial estimates
Financial estimateRevenue estimate
Valuation estimate
UterineKind leadership team
Management profileNumber of profiles
Profiles5 records
UterineKind funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UterineKind M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UterineKind
What does UterineKind do?
UterineKind is a direct-to-consumer women's health platform that combines a free mobile and Progressive Web App for daily symptom tracking with a paid 100-day Board Certified Patient Advocate (BCPA) care navigation subscription. The platform helps women with chronic gynecologic conditions document symptoms, generate structured reports for clinical visits, and receive personalized advocacy and care coordination from credentialed patient advocates.
Is UterineKind a public or private company?
UterineKind is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was UterineKind founded?
UterineKind was founded in 2022. It employs 1 to 10 people.
Where is UterineKind based?
UterineKind is headquartered in Boston, United States, in the North America region.
How does UterineKind make money?
Three revenue lines are on record. Care Navigation Program Subscription is the primary driver. The others are mobile Application (Free) and diagnostic Services Coordination.
Who are UterineKind's main competitors?
Broad incumbents on record are Kindbody, Tia, Maven Clinic and Hims & Hers (Hers). Direct peers are Clue, Wisp, Flo Health and Twentyeight Health. Emerging players are Mahmee and Elektra Health.
Does UterineKind have an API?
No public API is recorded for UterineKind.
What industry is UterineKind in?
UterineKind's product category is Digital Health Platform. Its primary akta.pro industry code is HLACANAK, Women’s Health & Fertility Therapeutics (Digital), with a secondary code of HLALAHAA, Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation). Its NAICS code is 621410 and its SIC code is 8000.